Analysts' ratings for Agilon Health (NYSE:AGL) over the last quarter vary from bullish to bearish, as provided by 5 analysts.

The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $6.2, a high estimate of $9.00, and a low estimate of $3.00. Experiencing a 9.88% decline, the current average is now lower than the previous average price target of $6.88.

Analyzing Analyst Ratings: A Detailed Breakdown

A...